RSV hospitalizations in US adults reached high levels pre-vaccine, especially impacting those 75 and older, underscoring the ...

RSV is a common cause of coughs and colds but can also lead to severe respiratory illness, especially in the most vulnerable.

Along with the effectiveness against severe outcomes, "we were also able to show that the vaccines worked well in adults 75 ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

A new study published today in JAMA Network Open shows that respiratory syncytial virus (RSV) was associated with a ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

As of last year, RSV vaccination with Abrysvo has been recommended for pregnant women in the United States from 32 to 36 ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...

As cold and flu season ramps up, the most vulnerable among us need extra protection. Infants are among the most susceptible ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...